ID   MAFF_HUMAN              Reviewed;         164 AA.
AC   Q9ULX9; B4DV49; Q9Y525;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2002, sequence version 2.
DT   07-APR-2021, entry version 175.
DE   RecName: Full=Transcription factor MafF;
DE   AltName: Full=U-Maf;
DE   AltName: Full=V-maf musculoaponeurotic fibrosarcoma oncogene homolog F;
GN   Name=MAFF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Term myometrium;
RX   PubMed=10527846; DOI=10.1006/bbrc.1999.1487;
RA   Kimura T., Ivell R., Rust W., Mizumoto Y., Ogita K., Kusui C.,
RA   Matsumura Y., Azuma C., Murata Y.;
RT   "Molecular cloning of a human MafF homologue, which specifically binds to
RT   the oxytocin receptor gene in term myometrium.";
RL   Biochem. Biophys. Res. Commun. 264:86-92(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, DNA-BINDING, AND INTERACTION WITH NFE2L1.
RX   PubMed=8932385; DOI=10.1093/nar/24.21.4289;
RA   Johnsen O., Skammelsrud N., Luna L., Nishizawa M., Prydz H., Kolstoe A.B.;
RT   "Small Maf proteins interact with the human transcription factor
RT   TCF11/Nrf1/LCR-F1.";
RL   Nucleic Acids Res. 24:4289-4297(1996).
RN   [6]
RP   INDUCTION.
RX   PubMed=11772409; DOI=10.1042/0264-6021:3610371;
RA   Moran J.A., Dahl E.L., Mulcahy R.T.;
RT   "Differential induction of mafF, mafG and mafK expression by electrophile-
RT   response-element activators.";
RL   Biochem. J. 361:371-377(2002).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH MIP.
RX   PubMed=16549056; DOI=10.1016/j.abb.2006.02.011;
RA   Ye X., Li Y., Huang Q., Yu Y., Yuan H., Wang P., Wan D., Gu J., Huo K.,
RA   Li Y.-Y., Lu H.;
RT   "The novel human gene MIP functions as a co-activator of hMafF.";
RL   Arch. Biochem. Biophys. 449:87-93(2006).
CC   -!- FUNCTION: Since they lack a putative transactivation domain, the small
CC       Mafs behave as transcriptional repressors when they dimerize among
CC       themselves (PubMed:8932385). However, they seem to serve as
CC       transcriptional activators by dimerizing with other (usually larger)
CC       basic-zipper proteins, such as NFE2L1/NRF1, and recruiting them to
CC       specific DNA-binding sites. Interacts with the upstream promoter region
CC       of the oxytocin receptor gene (PubMed:8932385, PubMed:16549056). May be
CC       a transcriptional enhancer in the up-regulation of the oxytocin
CC       receptor gene at parturition (PubMed:10527846).
CC       {ECO:0000269|PubMed:10527846, ECO:0000269|PubMed:16549056,
CC       ECO:0000269|PubMed:8932385}.
CC   -!- SUBUNIT: Monomer and homo- or heterodimer. Interacts with MIP
CC       (PubMed:16549056). Forms high affinity heterodimers with members of the
CC       CNC-bZIP family such as NFE2L1/NRF1 (PubMed:8932385).
CC       {ECO:0000269|PubMed:16549056, ECO:0000269|PubMed:8932385}.
CC   -!- INTERACTION:
CC       Q9ULX9; Q16236: NFE2L2; NbExp=2; IntAct=EBI-721128, EBI-2007911;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9ULX9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULX9-2; Sequence=VSP_043029;
CC   -!- TISSUE SPECIFICITY: Expressed in the term myometrium and kidney.
CC   -!- INDUCTION: By oxidative stress. {ECO:0000269|PubMed:11772409}.
CC   -!- SIMILARITY: Belongs to the bZIP family. Maf subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB025247; BAA86871.1; -; mRNA.
DR   EMBL; AJ010857; CAB52435.1; -; mRNA.
DR   EMBL; AK002001; BAA92029.1; -; mRNA.
DR   EMBL; AK300932; BAG62561.1; -; mRNA.
DR   EMBL; AL021977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015037; AAH15037.1; -; mRNA.
DR   EMBL; BC067751; AAH67751.1; -; mRNA.
DR   CCDS; CCDS13968.1; -. [Q9ULX9-1]
DR   CCDS; CCDS54528.1; -. [Q9ULX9-2]
DR   PIR; JC7112; JC7112.
DR   RefSeq; NP_001155044.1; NM_001161572.1. [Q9ULX9-1]
DR   RefSeq; NP_001155045.1; NM_001161573.1. [Q9ULX9-1]
DR   RefSeq; NP_001155046.1; NM_001161574.1. [Q9ULX9-2]
DR   RefSeq; NP_036455.1; NM_012323.3. [Q9ULX9-1]
DR   SMR; Q9ULX9; -.
DR   BioGRID; 117264; 39.
DR   IntAct; Q9ULX9; 19.
DR   MINT; Q9ULX9; -.
DR   STRING; 9606.ENSP00000345393; -.
DR   iPTMnet; Q9ULX9; -.
DR   PhosphoSitePlus; Q9ULX9; -.
DR   BioMuta; MAFF; -.
DR   DMDM; 21542145; -.
DR   EPD; Q9ULX9; -.
DR   jPOST; Q9ULX9; -.
DR   MassIVE; Q9ULX9; -.
DR   PaxDb; Q9ULX9; -.
DR   PeptideAtlas; Q9ULX9; -.
DR   PRIDE; Q9ULX9; -.
DR   ProteomicsDB; 85150; -. [Q9ULX9-1]
DR   ProteomicsDB; 85151; -. [Q9ULX9-2]
DR   Antibodypedia; 12337; 149 antibodies.
DR   DNASU; 23764; -.
DR   Ensembl; ENST00000338483; ENSP00000345393; ENSG00000185022. [Q9ULX9-1]
DR   Ensembl; ENST00000407965; ENSP00000384094; ENSG00000185022. [Q9ULX9-1]
DR   Ensembl; ENST00000426621; ENSP00000388882; ENSG00000185022. [Q9ULX9-1]
DR   Ensembl; ENST00000538320; ENSP00000442060; ENSG00000185022. [Q9ULX9-1]
DR   Ensembl; ENST00000538999; ENSP00000441482; ENSG00000185022. [Q9ULX9-2]
DR   GeneID; 23764; -.
DR   KEGG; hsa:23764; -.
DR   UCSC; uc003avc.4; human. [Q9ULX9-1]
DR   CTD; 23764; -.
DR   DisGeNET; 23764; -.
DR   GeneCards; MAFF; -.
DR   HGNC; HGNC:6780; MAFF.
DR   HPA; ENSG00000185022; Tissue enhanced (placenta).
DR   MIM; 604877; gene.
DR   neXtProt; NX_Q9ULX9; -.
DR   OpenTargets; ENSG00000185022; -.
DR   PharmGKB; PA30538; -.
DR   VEuPathDB; HostDB:ENSG00000185022.11; -.
DR   eggNOG; KOG4196; Eukaryota.
DR   GeneTree; ENSGT00940000161112; -.
DR   HOGENOM; CLU_112948_0_1_1; -.
DR   InParanoid; Q9ULX9; -.
DR   OMA; RSIKMDP; -.
DR   OrthoDB; 1395389at2759; -.
DR   PhylomeDB; Q9ULX9; -.
DR   TreeFam; TF325689; -.
DR   PathwayCommons; Q9ULX9; -.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SignaLink; Q9ULX9; -.
DR   SIGNOR; Q9ULX9; -.
DR   BioGRID-ORCS; 23764; 22 hits in 1008 CRISPR screens.
DR   ChiTaRS; MAFF; human.
DR   GeneWiki; MAFF_(gene); -.
DR   GenomeRNAi; 23764; -.
DR   Pharos; Q9ULX9; Tbio.
DR   PRO; PR:Q9ULX9; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9ULX9; protein.
DR   Bgee; ENSG00000185022; Expressed in amniotic fluid and 236 other tissues.
DR   ExpressionAtlas; Q9ULX9; baseline and differential.
DR   Genevisible; Q9ULX9; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007567; P:parturition; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045604; P:regulation of epidermal cell differentiation; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR004826; bZIP_Maf.
DR   InterPro; IPR033531; MafF.
DR   InterPro; IPR008917; TF_DNA-bd_sf.
DR   InterPro; IPR024874; Transcription_factor_Maf_fam.
DR   PANTHER; PTHR10129; PTHR10129; 1.
DR   PANTHER; PTHR10129:SF25; PTHR10129:SF25; 1.
DR   Pfam; PF03131; bZIP_Maf; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF47454; SSF47454; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Nucleus; Reference proteome; Repressor;
KW   Stress response; Transcription; Transcription regulation.
FT   CHAIN           1..164
FT                   /note="Transcription factor MafF"
FT                   /id="PRO_0000076497"
FT   DOMAIN          51..114
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          51..76
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          79..93
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   VAR_SEQ         1..29
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043029"
FT   CONFLICT        116
FT                   /note="G -> A (in Ref. 2; BAA86871)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   164 AA;  17760 MW;  FC34D9FF317E5EE1 CRC64;
     MSVDPLSSKA LKIKRELSEN TPHLSDEALM GLSVRELNRH LRGLSAEEVT RLKQRRRTLK
     NRGYAASCRV KRVCQKEELQ KQKSELEREV DKLARENAAM RLELDALRGK CEALQGFARS
     VAAARGPATL VAPASVITIV KSTPGSGSGP AHGPDPAHGP ASCS
//
